190 likes | 199 Views
Summary of the meeting on Value for Money in HIV/AIDS Bond, discussing the approach to measuring and accounting for value created by HIV/AIDS programs, challenges faced, and recommendations.
E N D
Value for Money in HIV/AIDS BOND meeting 3rd Feb 2011 Liza Tong International HIV/AIDS Alliance
Summary • Why value for money? • One approach to VfM, piloting SROI • What worked well • Challenges faced • Learning from the process • Recommendations
10 billion 10 000 8.9 billion 9000 Signing of Declaration of Commitment on HIV/AIDS,UNGASS 8000 US$ million 8.3 billion 7000 6000 World Bank MAP launch 5000 MONEY 4000 Gates Foundation PEPFAR 3000 UNAIDS Less than US$ 1 million 2000 1623 1000 Global Fund 292 257 212 59 0 1987 1990 1995 2000 2005 Notes: [1] 1986-2000 figures are for international funds only; [2] Domestic funds are included from 2001 onwards TIME [i]1996-2005 data: Extracted from 2006 Report on the Global AIDS Epidemic (UNAIDS, 2006); [ii] 1986-1993 data: Mann.&. Tarantola, 1996 Source: UNAIDS & WHO unpublished estimates, 2007 7.1 13 billion 2008
10 billion 10 000 8.9 billion 9000 Signing of Declaration of Commitment on HIV/AIDS,UNGASS 8000 US$ million 8.3 billion 7000 6000 VALUE World Bank MAP launch 5000 MONEY 4000 Gates Foundation PEPFAR 3000 UNAIDS Less than US$ 1 million 2000 1623 1000 Global Fund 292 257 212 59 0 MONEY 1987 1990 1995 2000 2005 Notes: [1] 1986-2000 figures are for international funds only; [2] Domestic funds are included from 2001 onwards TIME [i]1996-2005 data: Extracted from 2006 Report on the Global AIDS Epidemic (UNAIDS, 2006); [ii] 1986-1993 data: Mann.&. Tarantola, 1996 Source: UNAIDS & WHO unpublished estimates, 2007 7.1 13 billion Total available resources for AIDS 1986-2008 2008
VALUE ARV becomes available in developing countries MONEY Health benefit from investing in HIV prevention, care and treatment 200 150 Health Benefit 100 50 0 Global AIDS Expenditures Source: Stafano Bertozzi presentation at 5th IAS conference Cape Town June 2009
ARV becomes available in developing countries Health benefit from investing in HIV prevention, care and treatment 200 ECONOMIC CRISIS Two obvious responses: Strategies to maintain/increase funding levels Improve efficiency 150 ? ? Health Benefit 100 50 0 Global AIDS Expenditures Source: Stafano Bertozzi presentation at 5th IAS conference Cape Town June 2009
Health benefit from investing in HIV prevention, care and treatment 200 Two obvious responses: Strategies to maintain/increase funding levels Improve efficiency and effectivenss 150 Health Benefit 100 50 0 Global AIDS Expenditures Source: Stafano Bertozzi presentation at 5th IAS conference Cape Town June 2009
VfM in the field- Social return on investment • Alliance has adapted this framework to attempt to measure and account for value created by a programme, beyond financial value
So what is it ? • A way of assigning a value to social, environmental and economic value created by your programme • SROI is a framework for measuring and accounting for this broader concept of value • Describes changes are happening through measuring social, environmental and economic outcomes, using monetary values to represent these. • SROI = Value of benefits £1 of investment delivers £3 of social return Investment
Stages of SROI Reporting, using and embedding
CHAHA Started 2007Global Fund Round 6, 41 districts in the states of Maharashtra, Andhra Pradesh, Tamil Nadu and Manipur. Target 64,000 children by the end of January 2011
Challenges/limitations • The most common question we get asked at conferences these days is ‘Should I do a SROI?’. People are attracted to the number at the end: £2.50 of value created for every £1 put in. But they often don’t realise how big an undertaking a SROI is. For SROI to work the whole organisation needs to be bought into the process and be prepared to set up robust measurement systems.'New Philanthropy Capital April 2010
Lessons learned about the method • Participatory, end user perspective on VfM • Dispelled fear and misconceptions cost effectiveness=cost cutting • Need simplified brief approach to use with end-beneficiaries • Pilot SROI study conducted internally costs about $25 - $35k • Minimum systems of M&E to be in place to do an evaluative study • Use of focus groups and additional research, questionnaires and interviews • Requires broader research of potential financial proxies (databank of financial proxies!)
Recommendations • Compliments other evaluative studies • Best use: programme management tool • Robust M&E systems, SROI built into at outset • Forecast + Evaluative SROI • Adapted M&E training • Subjectivity and assumptions clearly documented